Skip to NavigationSkip to content


The UK's biggest cancer killer is the one of the most under-funded, according to a new map of cancer research.
Strategic health authorities are too far removed from PCTs to help them innovate as they work on their plans for the future, according to the NHS...
Aventis is on track to hit its full-year targets following strong third-quarter performance of key products.
The anonymous prankster behind the pharma industry satire has broken his silence in an exclusive interview with Pharmafocus.
The NHS is to be given more support to work in partnership with local authorities with the establishment of the Integrated Care Network.
Bristol-Myers Squibb has been forced to restate more than $2 billion of earnings as a result of what it terms a
French biotech company NicOx has seen its shares lose nearly 25% of their value after AstraZeneca abandoned a joint venture to development the new...